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1. Introduction 
Tuberculosis (TB), once regarded an historical disease due to the discovery of antibiotics, is 
one of the most wide-spread human infections today, and a major cause of death from 
bacterial infections. The causative agent, Mycobacterium tuberculosis, has evolved over ages 
along with the human species, the oldest human finding being 9 000 year-old skeletons with 
tuberculosis lesions (Hershkovitz, Donoghue et al. 2008). The most widely known form of 
tuberculosis, pulmonary TB, affects the lungs and is characterized by cough with bloody 
expectorations associated with fever, night sweats and weight loss. Extrapulmonary TB can 
be found almost anywhere in the body, either localized in organs such as the lymph nodes, 
pleura, abdomen, bones, joints and the central nervous system or appearing in a more 
disseminated form known as miliary TB. Active TB disease develops in 5-10% of infected 
individuals, whereas most exposed individuals contain the infection in the form of latent 
disease or more rarely eradicate the bacteria.  To prevent progression of latent TB to active 
disease, an equilibrium between the host and the microbe has to be maintained. Today, 
about one third of the world population are carriers of TB infection, which constitutes an 
enormous reservoir for potential spread of disease.  
1.1 Preface 
Despite decades of research on TB, studies of the cellular mechanisms involved in TB 
pathogenesis have lagged behind, particularly in human systems. In addition, TB 
immunology is a competitive area of research and available data is still controversial and 
often based on interpretations of results obtained from artificial experimental systems. The 
events associated with the induction and maintenance of M. tuberculosis-specific immune 
responses are complex and there are still many questions to be answered. This chapter 
describes the mechanisms by which M. tuberculosis manipulates host cell functions and the 
specific immune responses that are induced during mycobacterial infection. The balance 
between the bacteria and the host is delicate and a large number of research studies have 
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been devoted to better understanding of the critical factors involved in the cellular and 
molecular regulation of this balance. As will be discussed, the interplay between innate and 
adaptive immune responses as well as different cells of the immune system is closely 
interconnected. A complex network of cells at different locations and stages of 
differentiation contribute to the induction of the M.tuberculosis-specific immune responses 
and the regulation of TB disease. In order to understand the pathogenesis of TB, it is 
therefore necessary to study and relate host-specific immune responses to the 
microbiological and biochemical events initiated by the bacteria that result in the 
establishment and progression of M. tuberculosis infection. This chapter describes 
experiments ranging from macrophage infections to immunological analysis of pathogenesis 
in clinical tissue and cell samples obtained from the site of infection of TB infected patients. 
The presented methods include molecular analysis of mycobacterial cell wall components, a 
method for rapid determination of bacterial numbers and in situ quantitative image analysis. 
The chapter is based on current literature where animal models and patient materials is 
integrated with comprehensive cellular and tissue model systems, which are used to explore 
M. tuberculosis-specific host-pathogen interactions in human TB. Basic knowledge and the 
recent advances in the field of host-mycobacterial interactions and how pathogenic 
mycobacteria can manipulate and escape the immune system will be discussed with a 
special focus on the knowledge obtained with experimental models in relation to human TB.  
1.2 Mycobacterial structure 
M. tuberculosis is a rod-shaped bacterium belonging to the family of Mycobacteria 
(Mycobacteriaceae), which are gram-positive bacteria. The mycobacterial cell wall is rich in 
waxes and lipids, which contribute to the virulence of the bacteria in different ways (Shui, 
Petzold et al. 2011). Mycobacterial waxes are composed of diverse mycolic acids, which 
form a layer reminiscent of the outer membrane of Gram-negative bacteria (Bhamidi, 
Scherman et al.; Sani, Houben et al.). The waxy cell wall together with the recently described 
capsular layer, the major component of which is ┙-glucan, contribute to the  extraordinary 
resistance of mycobacteria to stresses such as drought, low pH and antibiotics (Sani, Houben 
et al.; Liu, Barry et al. 1996).  Pathogenic mycobacteria can regulate their cell wall thickness 
in response to stresses posed by host immunity (Cunningham and Spreadbury 1998) and 
there is recent evidence that the altered cell wall in stressed bacteria is refractory to acid-fast 
staining (Seiler, Ulrichs et al. 2003; Deb, Lee et al. 2009), a finding which may have important 
implications for diagnosis (Garton, Waddell et al. 2008). 
1.3 The immunological checkpoints M. tuberculosis needs to pass 
M. tuberculosis is a highly successful intracellular pathogen that has developed strategies to 
survive even in the presence of high immune pressure. The usual site of entry into the 
human body is through the airways, beginning with the inhalation of infected droplets 
expelled from another infected individual through coughing. The bacilli are transported into 
the respiratory tract to be engulfed by alveolar macrophages, cells that are designed to kill 
bacteria. Although being caused by a quite simple microorganism, TB is a multifaceted 
disease with a spectrum of antimicrobial effector pathways at play during different stages of 
infection, ranging from early innate to late adaptive immune responses during acute and 
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chronic infection. The infectious dose (the number of microorganisms required to cause 
infection) is very low, but nevertheless, most exposed individuals maintain the infection in a 
latent state. As the ability to control M. tuberculosis infection is strongly correlated with 
intact immune functions of the infected human host, individual differences in the ability to 
mount a proper immune response delivers an explanation for the low percentage of disease 
progressors. In order to cause active TB, M. tuberculosis has to pass several host immunity 
checkpoints (Barry, Boshoff et al. 2009).  These checkpoints, illustrated in figure 1, include 
the initial attacks posed by innate immune mechanisms and the following adaptive immune 
response.  
1.3.1 Checkpoint one: Avoiding being killed by the macrophage 
The first checkpoint that M. tuberculosis has to overcome is to prevent itself from being killed 
by the antimicrobial effector mechanisms harboured by macrophages. Macrophage effector 
mechanisms include acidification of the phagosome, exposure to proteases and 
antimicrobial peptides and the generation of reactive oxygen and nitrogen species. The 
pathogen has evolved strategies to evade and/or tolerate these stresses, and manages to 
survive in cells that are otherwise effective killers of most microorganisms. However, there 
may be circumstances under which the bacteria are actually eradicated inside the human 
host. For example, it is well established that many subjects, who are continuously exposed 
to M. tuberculosis (e.g. household contacts of TB patients), do not display any immunological 
memory of the pathogen, as evidenced by the lack of reaction to interferon- release assays 
(IGRA) and tuberculin skin test (TST). These individuals possibly exert a massive innate 
immune pressure on the inhaled pathogens, making any adaptive immune reaction 
unnecessary. A clue to the mechanism behind this phenomenon comes from the observation 
that healthy household contacts of TB-patients produce high amounts of bactericidal 
compound nitric oxide (NO) (Idh, Westman et al. 2008). Although this observation needs 
further confirmation in human in vitro systems, it is possible that the ability of macrophages 
to produce sufficient amounts of NO actually allows the innate immune system to eradicate 
M. tuberculosis infection.  
1.3.2 Checkpoint two: Defeating innate immunity 
Failure of innate immune mechanisms to control the growth of the bacteria, possibly related 
to insufficient production of NO and other immune mediators, admits M. tuberculosis 
through the second checkpoint, after which adaptive immunity becomes important. The 
increasing immune pressure mounted by the adaptive immunity restores the immunological 
control. Latent TB is characterized by immune reactivity towards TB antigens (e.g. IGRA or 
TST) along with absence of any clinical symptoms. In the lungs tissues, healed or active 
granulomatous lesions at different stages may be present. Individuals with latent TB include 
non-progressors, in whom the infection is kept at equilibrium through host immune 
mechanisms and progressors, in whom the infection progresses towards active disease.  
1.3.3 Checkpoint three: Defeating adaptive immunity 
As long as immune control is maintained, M. tuberculosis infection is kept latent; however, 
sooner or later, the bacterium may take advantage of a declining immunocompetence of the 
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host, e.g. due to ageing, malnutrition, drug abuse, HIV infection or other 
immunosuppressive diseases or drug treatments. Thus, by passing the last checkpoint of 
adaptive immunity M. tuberculosis will inevitably cause its host to transmit the infection and 
eventually succumb, if left untreated. On the following pages, we will describe the 
protective immune defence mechanisms and the strategy that M. tuberculosis employs to get 
beyond these checkpoints. 
 
Fig. 1. The checkpoints that M. tuberculosis has to pass in order to cause TB. Checkpoint 1 is 
to avoid being killed by the very early immune mechanisms. Checkpoint 2 is to overcome 
innate immune control and thereby passing on to presentation to adaptive immunity. 
Checkpoint 3 is to defeat the effector mechanisms of adaptive immunity. The lost immune 
control admits effective replication of bacteria, which leads to necrosis and spread to other 
individuals. 
2. Beyond checkpoint one: Establishment of M. tuberculosis infection 
As mentioned above, the macrophage is the major host cell for M. tuberculosis infection, and 
the alveolar macrophage is described as the first cell that encounters M. tuberculosis on its 
journey within the host. As it is difficult to investigate the very initial events of 
mycobacterial infection in a living host, a major part of the studies on initial events is 
performed with macrophages monocultures, most often cell lines of human or murine origin 
or with macrophages derived from human or murine monocytes. It is well established that 
production of NO is strongly induced in murine macrophages during mycobacterial 
infection, but that isolated human macrophages fail to do the same upon in vitro infection. 
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Thus, there are important differences between mouse and human macrophages, which 
suggests that different macrophage immune mechanisms may exist in the two species. It is 
also important to realise that macrophages are heterogeneous even if obtained from the 
same individual and thus can have substantially different phenotypes depending on the 
protocol used for differentiation. In the body, the circulating precursor cells, the monocytes, 
are already heterogeneous when they enter the blood stream from the bone marrow. 
Subsequent differentiation in the various tissues further adds to the complexity. 
Nevertheless, experiments performed with pure macrophage cultures have substantially 
contributed to the understanding of M. tuberculosis. 
2.1 Manipulation of phagosomal maturation 
The alveolar macrophage is able to take up microorganisms into a vacuole that subsequently 
undergoes a process known as phagosomal maturation, where a series of fusion and fission 
events takes place to localize microbicidal activity to the vacuole. M. tuberculosis has evolved 
mechanisms to inhibit this process, and these mechanisms have been studied in detail (for 
review, see Vergne, Chua et al. 2004). The process of phagosomal maturation is traditionally 
viewed as a gradual process of complete fusion of lysosomes, which contain microbicidal 
effector molecules, with phagosomes. However, it turns out that this process is much more 
complex and selective than previously thought. Desjardins suggested that phagosomal 
maturation is a continuous process of fusion and fission of cellular organelles, the transfer of 
membranes and materials from these being a rather transient and highly specific event 
(Desjardins, Houde et al. 2005). There is evidence in the literature for separate sources of 
lysosomal proteins such as LAMPs and the proton pumps that are required for lowering the 
phagolysosomal pH. Whereas LAMPs can be found on both lysosomes and endosomes, the 
proton pumps can be recruited to the phagosome from the ER. Therefore, studies solely 
based on traditional markers for phagolysosomal fusion such as LAMPs may not reflect the 
actual milieu inside the phagolysosome. Instead, assays addressing more functional aspects 
of the phagosome must be employed. Fully matured phagolysosomes are known to have a 
pH  below 5.0 (Russell, Vanderven et al. 2009), and the low pH is a prerequisite for 
functionality of the proteolytic, degradative enzymes delivered by lysosomes. Thus, 
phagosomal acidification, which can be studied using pH-reactive, fluorescent dyes, is a 
correlate of phagosomal activity. 
2.1.1 Inhibition of phagosomal maturation through lipoarabinomannan 
Mycobacterial lipids are known to be important for the bacterium to resist the host immune 
functions, the waxes being more like passive protectors, whereas other lipids exert more 
specific effects. The most studied glycolipid, lipoarabinomannan (LAM), is composed of 
glycophosphatidyl inositol (GPI), which functions as a lipid anchor, and a branched 
arabinomannan residue that extends through the mycobacterial cell wall to be exposed on 
the outside of the bacterium (Shui, Petzold et al. 2011). LAM differs between virulent, slow 
growing mycobacteria and their non-virulent, fast-growing relatives in that the virulent 
species carry mannosylated LAM (ManLAM) (Dao, Kremer et al. 2004). ManLAM has been 
shown to inhibit phagosomal maturation in both murine and human macrophages (Fratti, 
Chua et al. 2003; Hmama, Sendide et al. 2004; Kang, Azad et al. 2005), thus playing a central 
role in manipulation of an important host cell function. LAM can interact with different 
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receptors on the host cell surface, including the mannose receptor and the complement 
receptor (Le Cabec, Carreno et al. 2002; Kang, Azad et al. 2005) and during prolonged 
infection of cell cultures, the glycolipid is trafficked throughout the membrane 
compartments of the host cell (Xu, Cooper et al. 1994). In fact, LAM can be detected in the 
urine of TB-patients, illustrating the extensive distribution of this molecule in M. 
tuberculosis-infected hosts (Hamasur, Bruchfeld et al. 2001). Although the ability of LAM to 
inhibit phagosomal maturation is well established, the mechanism by which it causes this 
effect has not been addressed by many groups. To date, there is no mycobacterial strain, 
which is specifically deficient in the production of ManLAM, making mechanistic studies 
difficult. A frequently used model to study LAM function is based on LAM-coated latex 
beads (Hmama, Sendide et al. 2004; Kang, Azad et al. 2005), and these studies have 
provided evidence for the inhibitory effect of ManLAM on phagosomal maturation but 
failed to provide a  mechanism by which this occurs. In order to allow mechanistic studies 
of LAM functions, we created a unique model based on the previously established fact that 
LAM can be intercalated into the host cell membrane via its GPI anchor (Ilangumaran, Arni 
et al. 1995). Assuming that at least initially, the membrane surrounding the phagosome is 
more or less derived from the plasma membrane, we allowed cells that had incorporated 
LAM in their plasma membrane to phagocytose opsonised zymosan particles. Resulting 
phagosomes displayed a reduced ability to attract markers of phagosomal maturation in 
comparison to control conditions (Welin, Winberg et al. 2008), a phenomenon which was 
dependent on the ability of LAM to incorporate into the lipid rafts. There are ongoing 
studies investigating this phenomenon in more detail (Torrelles and Schlesinger 2011). 
Albeit a totally unrelated pathogen, the protozoan parasite Leishmania donovani carries a 
glycolipid lipophosphoglycan (LPG), which is structurally related to LAM, in its cell 
membrane. In analogy with LAM, LPG is shed into the lipid rafts of host macrophages 
during infection with L. donovani, also causing inhibition of phagosomal maturation, thereby 
providing the parasite with a suitable niche inside the host cell (Winberg, Holm et al. 2009). 
2.1.2 The abilities of non-virulent vs. virulent strains to manipulate host cell functions 
Many studies on the ability of M.tuberculosis to inhibit phagosomal maturation are based on 
the attenuated vaccine strain of M. bovis, better known as Bacillus Calmette-Guérin (BCG). 
Although this strain is not able to grow inside macrophages or to cause disease (at least not 
in immunocompetent individuals), it seems to be as capable as virulent strains of its relative, 
M. tuberculosis to manipulate phagosome functions (Jayachandran, Gatfield et al. 2008; Sun, 
Wang et al. 2010). Indeed, LAM from the BCG strain is of the ManLAM type, showing no 
major structural difference to ManLAM from virulent strains (Prinzis, Chatterjee et al. 1993). 
Thus, the BCG strain and other attenuated strains of M. tuberculosis can be exploited as a 
relevant model for initial events during mycobacterial infection (Rhoades, Hsu et al. 2003; 
Jayachandran, Sundaramurthy et al. 2007). The reason for the lacking virulence of BCG is 
attributed to the deletion of the Region of Difference-1 (RD1) in its genome (Lewis, Liao et 
al. 2003). This region encodes a Type VII secretion system and proteins that are secreted via 
this system. These proteins, termed Early Secreted Antigenic Target-6 (ESAT-6) and Culture 
Filtrate Protein-10 (CFP-10) have both been identified as important for virulence (Smith, 
Manoranjan et al. 2008). Interestingly, they seem to be secreted as a one-to-one complex, the 
CFP-10 protein being a putative chaperone to assist ESAT-6 folding (de Jonge, Pehau-
Arnaudet et al. 2007). There is no evidence of a role for ESAT-6 for the inhibition of 
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phagosomal maturation, but instead it is involved in the events that takes place after the 
initial uptake. Therefore, extended infection experiments are required to obtain a more 
holistic picture of M. tuberculosis infection. 
2.2 The interaction between M. tuberculosis and the macrophage during prolonged 
infection 
Most of the earlier studies on the interaction of M. tuberculosis with the host macrophage are 
based on short-term experiments of a few hours up to one day. Until recent years, 
researchers have underestimated the importance of extended infection experiments to study 
a chronic infection with a slow-growing bacterium such as M. tuberculosis. Thus, later 
studies performed with human macrophages and virulent bacteria have provided insight 
into the broader strategy of M. tuberculosis, which is certainly not limited to a life within a 
vacuole. Instead, it seems that the pathogen, after adapting to the intracellular environment 
by interfering with phagosomal maturation, will disrupt the phagosome, enhance 
replication and eventually kill the host cell.  
2.2.1 New experimental models for studies of M. tuberculosis interaction with the host 
macrophage 
As outlined above, the fate of mycobacteria inside macrophages is more difficult to 
predict than previously assumed and it becomes crucial to study mycobacterial 
replication inside macrophages under varying conditions. The available methods for 
assessment of intracellular bacterial growth have long been limited to viable counts or 
incorporation of radioactive markers into growing bacteria. Therefore, alternative 
methods for these studies of M. tuberculosis that could be performed more effectively are 
convenient. Such methods, run on a medium-throughput scale, allow more thorough 
analysis of intracellular fate of M.tuberculosis in terms of extended time of infection, 
bacterial factors contributing to the ability of the bacterium to establish infection and 
varying conditions that support the host cell to control the infection. To this end, we 
validated the use of M. tuberculosis bacteria, engineered to express luciferase, against the 
gold standard determination of colony forming units (CFU). We found that luciferase-
based determination of bacterial numbers was actually superior to the CFU-method in 
accuracy as determined by intraassay variation (Eklund, Welin et al. 2010) when run in a 
96-well plate format. The use of luciferase, which requires a co-factor, FMNH2 that is 
present only in living bacteria, allows inclusion of viable bacteria only.  Fluorescent 
markers such as GFP are also used to enumerate bacteria; however, a loss of viability does 
not necessarily correlate with loss of fluorescence. Many studies that measure replication 
of mycobacteria inside cells do not include parallel measurements of extracellular and 
intracellular bacteria. The easy handling of the 96-well plates and the efficient readings 
with the plate reader with luminometry function admit measurements of both 
extracellular and intracellular growth, without the need for additional manipulation of 
the system (e.g. addition of extracellular antibiotics). Another shortcoming of many 
studies on intracellular growth of mycobacteria is that cell viability is not addressed. If the 
number of bacteria is determined in a lysate of adherent cells, it is very important to know 
how many cells were left, as loss of cells would result in loss of measurable bacteria. Thus, 
many studies that conclude that mycobacteria were killed by the macrophages cannot rule 
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out cell loss as cause of reduced numbers of CFUs. The use of luminometry for 
determination of bacterial numbers as in our system allows fluorescence-based 
measurement of cell viability in the same wells, which gives reliable data on the host-
pathogen balance in the individual experiments.   
2.2.2 Phagosomal acidification and control of mycobacterial growth 
Using the described method, we have established that depending on the initial bacterial 
load, non-activated human macrophage cultures will experience different fates when 
infected with virulent M. tuberculosis. Whereas a higher bacterial load results in effective 
bacterial replication and rapid cell death (further discussed below); a lower bacterial load 
results in a state where the macrophage controls the pathogen. The latter situation provides 
us with a tool to study the immune mechanisms that the macrophage employs to control the 
infection (“balanced infection”).  
By assessing the macrophage functions that were at play during the balanced infection, we 
narrowed down acidic pH of the phagosome and functional cathepsin D as essential for 
controlled infection, whereas the generation of reactive oxygen species did not appear to 
play a role in this context (Welin, Raffetseder et al. 2011). We found that the restricted 
intracellular growth of M.tuberculosis the ability of the macrophage to acidify phagosomes, 
but not to translocate LAMPs. This finding is supported by earlier studies, where the proton 
pumps (v-ATPase) but not LAMP-1, were excluded from mycobacterial phagosomes 
(Sturgill-Koszycki, Schlesinger et al. 1994). We were not able to delineate whether the acidic 
pH itself was harmful to the bacteria, but given the relative resistance of mycobacteria to 
low pH, it was more likely the activation of hydrolytic enzymes (such as cathepsin D) inside 
the acidic compartments that conveyed the killing activity.  
2.2.3 Killing of M. tuberculosis or just growth restriction 
The reduction of the net growth of the bacteria observed with the balanced infection could 
be explained by either absence of growth or by a steady-state between growth and killing. 
Importantly, we have never been able to see a reduction in bacterial numbers using the 
human macrophages, which would point to a net killing of bacteria. Other groups have 
reported killing of mycobacteria by macrophages (Thoma-Uszynski, Stenger et al. 2001; 
Fortune, Solache et al. 2004), however, many reports interpret reduced growth of 
mycobacteria as killing. Ehrt and colleagues showed that even in IFN--activated mouse 
macrophages, virulent M. tuberculosis were not killed but rather subject to growth 
restriction (Vandal, Pierini et al. 2008). Only deletion of a specific membrane protein of M. 
tuberculosis, Rv3671c, resulted in loss of bacterial viability. The authors further showed 
that this virulence factor is crucial for the maintenance of intrabacterial pH, as assessed by 
a pH sensitive variant of GFP. Together, these studies suggest that replication and 
induction of host cell death is only one strategy employed by M. tuberculosis when it 
enters the cell. The other strategy, which occurs if the macrophage is able to mount a 
significant level of phagolysosomal activity, is to switch the phenotype to a slower growth 
rate associated with  enhanced ability to resist the harsh environment inside the host cell, 
allowing it to persist for extended time. Thus, the inhibition of phagosomal maturation 
may be rather a means to buy time to induce the optimal phenotype. Ageing of the 
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macrophage eventually unleashes the growth, but as long as immunosurveillance is 
strong, uptake by neighbouring cells will not result in significant net growth. This 
hypothesis is summarized in figure 2. 
 
Fig. 2. Schematic view of two strategies that M. tuberculosis employs during infection of the 
macrophage. The first one (I) is to replicate after successfully inhibiting phagosomal 
maturation. The second (II), which can be used if the macrophage manages to acidify the 
phagosome, is to switch to a phenotype that tolerates the stresses posed by the macrophage. 
Ageing of the macrophage eventually allows the bacterium to resume growth. 
2.2.4 Host-protective apoptosis vs. detrimental necrosis 
In 2007, Peter Peters and colleagues demonstrated that M. tuberculosis can, like the close 
relative M. marinum (Stamm, Morisaki et al. 2003), escape from the phagosome and replicate 
inside the macrophage cytoplasm (van der Wel, Hava et al. 2007).  The issue has been a 
matter of contradiction during the past few years and many studies have emphasized the 
absence of bacilli void of phagosomal membranes in many experimental settings and cells 
obtained from infected humans. Given the facts that host cell death follows the 
mycobacterial escape from the phagosomes and that remnants of dead cells are rapidly 
removed in tissues by residual macrophages, it is logical to assume that any such event is 
difficult to capture in alveolar macrophages and tissues. Regardless, the protocols used for 
preparation of and the origin of macrophages (mouse vs. man) may be crucial determinants 
of the outcome for M. tuberculosis during experimental infection, and this may cause 
different results in the hands of different research groups. The mechanisms by which the 
phagosomal escape occurs are currently being investigated. A favoured candidate is ESAT-
6, which plays an important role for the phagosomal escape in M. marinum, probably 
through its membrane-damaging properties (Smith, Manoranjan et al. 2008). In any case, 
phagosomal escape is likely to precede host cell death. There is conflicting evidence for the 
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mode of cell death induced by M. tuberculosis. In fact, there is convincing evidence that M. 
tuberculosis actively prevents apoptosis by the action of the protein nuoG (Velmurugan, 
Chen et al. 2007). The mechanism, by which this occurs, remains elusive, but a microbial 
rationale for apoptosis prevention is that this mode of cell death seems to be lethal to 
intracellular pathogens (Keane, Remold et al. 2000). In contrast to apoptotic cell death, 
which proceeds in a programmed, quiescent manner to avoid excessive inflammation, 
necrosis is an uncontrolled loss of cell integrity caused by different kinds of stresses such as 
mechanical forces, heat or infections. Typically, cellular contents, such as ATP, High 
Mobility Group Box (HMGB)-1 protein and DNA are released in the extracellular matrix. 
These endogenous danger signals attract the attention of innate immunity by interacting 
with purinergic and pattern recognition receptors, causing release of inflammatory 
cytokines and chemokines. Active tuberculosis lesions are associated with excessive 
inflammation and necrosis. It is a matter of debate whether inflammation is good or bad for 
M.tuberculosis. An illustrative example comes from the observations with IL-1┚. This pro-
inflammatory cytokine is crucial for the control of mycobacterial infection in mice as 
deficiencies in the production of the cytokine or its receptor causes more severe symptoms 
(Sugawara, Yamada et al. 2001; Mayer-Barber, Barber et al. 2010). On the other hand, M. 
tuberculosis has been shown to activate the NLRP3 inflammasome, which is a protein 
complex responsible for IL-1┚ production in macrophages (Petrilli, Dostert et al. 2007). 
Mycobacteria-induced production of IL-1┚ causes destructive inflammation in the mouse, 
the conclusion being that IL-1┚ is deleterious for the host (Carlsson, Kim et al.). Thus, IL-1┚ 
can act like a double-edged sword, in analogy to the pro-inflammatory cytokine TNF-┙, 
which is required for TB control, but is also a component of accelerated inflammation 
during disease progression (Mootoo, Stylianou et al. 2009). 
The recently described modes of cell death termed pyroptosis and pyronecrosis due to the 
association with the pyrogenic (fever-causing) cytokine IL-1┚, has been described to occur 
during Salmonella and Neisseria infection, respectively (Fink and Cookson 2007; Duncan, Gao 
et al. 2009). As we found that a higher bacterial load resulted in cell death and a massive 
release of IL-1┚, we sought to determine whether either of these novel modes of cell death 
was at play. Thorough analysis of the pattern of cell permeability, nuclear fragmentation 
and mitochondrial damage pointed to a more disorganized form of cell death of human 
macrophages infected with virulent M. tuberculosis. Any attempt to inhibit apoptosis 
(Caspase-dependent), pyroptosis (Caspase-1-dependent) and pyronecrosis (Cathepsin-B-
dependent) failed, suggesting that the fate of the cells was necrosis. We turned to investigate 
the microbial factors that were causing necrosis, selecting ESAT-6 as a possible candidate. 
Deletion of this well-known but poorly understood mycobacterial virulence factor showed a 
clear relationship with the necrosis-causing ability of M. tuberculosis. Another report arrived 
at the same conclusion that macrophages are killed by M. tuberculosis in a necrosis-like 
fashion. However, the authors correlated the ability of the bacterium to induce cell death to 
functional PhoP two-component signalling instead of an intact RD-1 locus, in which ESAT-6 
and the ESX-1 machinery is localized. The reason for this discrepancy remains elusive, but 
again, the different cell types used (human monocyte-derived macrophages in our study vs. 
bone-marrow-derived mouse macrophages in the other study) are possible reasons for the 
differing results.  
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3. Beyond checkpoint two: Interplay between innate and adaptive immunity 
and M. tuberculosis  
As described above, M. tuberculosis is able to survive within the host even during a strong 
inflammatory response. The ability of the bacterium to enter and persist in the phagosomal 
system (Clemens and Horwitz 1995) is essential for establishment of infection, but also to 
avoid and/or manipulate protective host immune responses (Flynn and Chan 2003). 
Elucidation of the immune mechanisms that control the initial infection and prevent 
reactivation of latent TB is ongoing. Certainly genetic and environmental variations exist 
within the human population that may significantly affect an individual’s susceptibility to 
develop active TB disease. However, pathogenic mycobacteria and their virulence factors 
can also modulate specific host immune responses, delay the onset of crucial anti-TB 
immunity and evade antimicrobial effector functions. Pathogenic mycobacteria are well 
adapted to the human host and have a range of complementary evasion mechanisms that 
contribute to the ability to avoid elimination by the immune system and establish a 
persistent infection (Tufariello, Chan et al. 2003; Gupta, Sharma et al. 2010). A close interplay 
between both innate (Jordao and Vieira 2011) and adaptive (Urdahl, Shafiani et al. 2011) 
antimicrobial effector pathways are required to control the progression of M. tuberculosis 
infection. Since the induction of the adaptive immune response including clonal expansion 
of antigen-specific T cells takes time, the innate immune system provides a first line of 
defence upon infection. In this section, we describe and discuss different antimicrobial 
effector pathways that are vital to maintain a balance between the mycobacteria and its host.   
3.1 Induction and regulation of innate immune responses in M. tuberculosis infection 
While macrophages are the primary host cell to be infected with M. tuberculosis, providing a 
shelter for growing bacteria, macrophages are also key effector cells with the ability to 
eliminate intracellular bacteria. Another innate immune cell with important antigen 
presenting and T cell activating functions is the dendritic cell (DC). Both macrophages and 
DCs are major players in the induction of proinflammatory responses in the early stages of 
TB infection and later on bridge innate immunity to the adaptive immunity. 
3.1.1 Nitric oxide 
In the initial phase of M. tuberculosis infection, infected host macrophages can be activated to 
become bactericidal by producing compounds such as oxygen and nitrogen radicals, 
primarily NO, which is important in order to restrict intracellular growth of bacteria. NO 
has been shown to be critical to control M. tuberculosis infection in mice (Chan, Xing et al. 
1992; MacMicking, North et al. 1997; Scanga, Mohan et al. 2001; Reece, Loddenkemper et al. 
2011) and it was recently shown that NO-mediated apoptosis of M. tuberculosis-infected 
murine macrophages was required for efficient mycobacterial killing (Herbst, Schaible et al. 
2011). Moreover, inhibition of phagolysosomal maturation mediated by the M. tuberculosis-
specific lipid trehalose dimycolate (TDM) is fully abrogated in IFN-/LPS-activated murine 
macrophages and involves NO synthase (NOS2) and reactive nitrogen intermediates (RNI), 
which suggests that macrophage-specific NO can promote inactivation of a mycobacterial 
molecule with an essential virulence function (Axelrod, Oschkinat et al. 2008). These results 
also support the assumption that NO-mediated mycobacterial clearance is dependent on 
acidification of M. tuberculosis-containing phagosomes (MacMicking, Taylor et al. 2003). 
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Despite substantial evidence of a protective role of NO in the mouse, the importance of NO-
mediated elimination of M. tuberculosis in humans is controversial. Our group as well as 
others have used immunohistochemistry or mRNA analysis to show that NO expression can 
be detected in human M. tuberculosis-infected macrophages in vivo (Nicholson, Bonecini-
Almeida Mda et al. 1996; Nathan 2002; Schon, Elmberger et al. 2004; Andersson, Samarina et 
al. 2007). There is also a synergistic effect of vitamin D and IFN- treatment to enhance M. 
tuberculosis-induced NO synthesis and bacterial killing in human monocyte-derived 
macrophages in vitro (Lee, Yang et al. 2009). Inhibition of NO-production in vitro using 
compounds such as L-NMMA or NMA promote intracellular M. tuberculosis growth, which 
suggests that NO indeed has a significant function in the human defence against M. 
tuberculosis (Jagannath, Actor et al. 1998). However, some strains of M. tuberculosis have 
developed strategies to neutralize the actions of NO and RNI by expressing a detoxifying 
protein encoded by the AhpC gene (Chen, Xie et al. 1998; Master, Springer et al. 2002). 
Interestingly, apart from its bactericidal activity, NO may possess regulatory effects on T cell 
activation leading to impaired effector functions (Bingisser, Tilbrook et al. 1998; Angulo, de 
las Heras et al. 2000; Hoffman, Mahidhara et al. 2002). As local production of oxidative 
stress and NO may severely impair the immune system, these effectors can mediate both 
beneficial and detrimental effects during mycobacterial infection. 
Whereas NOS2 gene-disrupted mice have been used to show that NO and RNI are required 
to control murine TB (Scanga, Mohan et al. 2001; Reece, Loddenkemper et al. 2011), most 
methods to evaluate the relevance of NO in humans are indirect and dependent on 
detection of different NO synthases or specific NO-metabolites such as nitrate. Thus, reliable 
methods for direct assessment of NO are missing. The detection of NO radicals in tissues is 
particularly difficult due to the short lifetime and relatively low concentration of these 
compounds. Hence, better techniques are required to be able to test if the expression of NO 
synthases corresponds to the induction of an active enzyme. Simultaneous assessment of the 
NO synthase and metabolites can be used to overcome part of this problem. Furthermore, 
an important difference between mouse and human macrophages is their ability to induce 
either NO or the NO synthase in vitro. It is widely accepted that LPS and IFN- can be used 
to activate robust NO production in murine macrophages, while very few publications show 
a similar induction of NO in human macrophages in vitro. The failure to induce NO in 
human macrophages under the same conditions that works for mouse macrophages (Arias, 
Zabaleta et al. 1997), support the hypothesis that NO possibly plays a more profound role in 
murine TB compared to human TB. It will be a future challenge to develop better model 
systems to continue to study and evaluate the bactericidal function of NO in human TB and 
also in relation to the potential suppressive effects on T cell responses at the site of TB 
infection. In this regard, we are currently establishing TB infection in a lung tissue model 
that we use to mimic human TB infection in the context of a more relevant physiological 
environment. The model consists of 3-dimensional organotypic cultures of stromal cells as 
well as primary human macrophages infected with virulent M. tuberculosis, which provides 
us with an experimental tool that can be used for mechanistic studies on human TB.  
3.1.2 Antimicrobial peptides 
Innate immune effector mechanisms in TB also include the induction and action of 
antimicrobial peptides (AMPs) such as human cathelicidin, LL-37 (Liu, Stenger et al. 2007; 
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Martineau, Newton et al. 2007). These are small cationic molecules, with the potential to kill 
microbes at mucosal surfaces. In addition to its antimicrobial properties, LL-37 is pro-
inflammatory and could stimulate migration of various cell types (Coffelt, Marini et al. 2009) 
and also affect the inflammatory functions of neutrophils. Importantly, AMPs may be 
crucial to prevent initial uptake of mycobacteria in the respiratory tract. It has also been 
shown that LL-37 confers protection against M. tuberculosis infection by the induction of 
autophagy in human monocytes (Yuk, Shin et al. 2009). Autophagy is an important 
physiological process that involves degradation of intracellular components after fusion of 
autophagosomes and lytic lysosomes. Among other functions, autophagy is an important 
defence mechanism to inhibit intracellular survival of mycobacteria since it can overcome 
the phagosomal maturation block induced by M.tuberculosis (Gutierrez, Master et al. 2004). 
Although activated by different signalling pathways, the induction of both LL-37 and 
autophagy in human macrophages is dependent on the presence of active vitamin D. It is 
well known that individuals with vitamin D deficiencies have an increased susceptibility to 
TB, which may be associated with reduced production of LL-37 as well as reduced 
autophagy (Liu, Stenger et al. 2006; Liu, Stenger et al. 2007). Our unpublished observations 
suggest that vitamin D deficiency in a cohort of Russian TB patients with chronic pulmonary 
TB correlates with reduced levels of LL-37 in pulmonary TB lesions. More studies are 
needed to investigate the regulation of LL-37 expression in vivo and in vitro and whether 
mycobacteria have developed strategies to circumvent the function of this antimicrobial 
peptide.   
3.1.3 Toll-like receptors 
The capacity of the innate immune system to recognize foreign antigens is restricted to a set 
of conserved molecular patterns called pathogen-associated molecular patterns (PAMPs). 
The receptors for PAMPs are called pattern-recognition receptors (PRR), to which the Toll-
like receptors (TLRs) belong. TLRs are PRRs that specifically recognize certain microbial 
antigens, including mycobacterial proteins and lipids. Antigen presenting cells (APCs), such 
as macrophages and DCs, express several different TLRs, which control the activation and 
induction of antimicrobial functions in the cells. Furthermore, TLR-stimulated APCs will 
interact with M. tuberculosis-specific T cells and induce clonal differentiation and expansion 
of these T cells. During mycobacterial infection, recognition by TLR 1, 2, 4, 8 and 9 are 
important for maturation of APCs including up-regulation of antigen-presenting molecules, 
production of inflammatory cytokines and chemokines and also the induction of 
antimicrobial effector functions (Means, Wang et al. 1999). TLRs mainly recognize lipid-rich 
mycobacterial molecules such as LAM (van Crevel, Ottenhoff et al. 2002) and TDM 
(Bowdish, Sakamoto et al. 2009). TLR2/1 activation, which triggers LL-37 production in a 
Vitamin D-dependent manner, has been shown to enhance the killing of M. tuberculosis 
bacilli in human macrophages (Liu, Stenger et al. 2006). In addition, mycobacterial cell wall 
products can regulate CD1 antigen presentation through TLR2 signalling (Roura-Mir, Wang 
et al. 2005). On the other hand, pathogenic mycobacteria have developed mechanisms to 
manipulate TLR-induced signalling pathways and may thus suppress important 
antimycobacterial immune responses (van Crevel, Ottenhoff et al. 2002; Bowdish, Sakamoto 
et al. 2009). In this regard, M. tuberculosis ManLAM can bind to the C-type lectin DC-SIGN 
on the surface of DCs and actively interfere with TLR-mediated DC maturation 
(Geijtenbeek, Van Vliet et al. 2003). Prolonged exposure to M. tuberculosis 19kD lipoprotein 
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inhibits MHCII expression as well as alternative MHC-1 antigen processing and 
presentation by IFN- activated macrophages via TLR2, which may allow the bacteria to 
decrease recognition by CD4+ and CD8+ T cells and maintain chronic infection (Noss, Pai et 
al. 2001; Tobian, Potter et al. 2003; Pecora, Gehring et al. 2006). The ESAT-6 protein of M. 
tuberculosis can also interact with TLR2 and inhibit TLR signalling in macrophages in order 
to restrict innate immune responses (Pathak, Basu et al. 2007). Moreover, an elegant study 
recently provided strong evidence that active release of mycobacterial vesicles contain TLR2 
lipoprotein agonists, which contribute to an enhanced pulmonary inflammation and 
progression of TB in infected mice (Prados-Rosales, Baena et al.). Cytokine analysis 
indicated the induction of atypical proinflammation since large amounts of 
immunosuppressive IL-10 was also produced by macrophages treated with mycobacterial 
vesicles. Altogether, these studies show that TLR interactions with M. tuberculosis ligands 
can activate antimicrobial and antigen presenting functions of macrophages and DCs but 
can also be exploited by the bacteria to escape the host immune response. 
3.2 Induction and regulation of adaptive immune response in M. tuberculosis infection 
Induction of cell-mediated immunity and the formation of a granulomatous response are 
mandatory in human TB. Many immune cells are involved in this process that is guided by 
CD4+ helper T cells and CD8+ cytolytic T cells (CTLs). These T cell subsets possess 
complementary and interacting functions, which are therefore hot targets for mycobacterial 
manipulation, as improper activation of this arm of immunity facilitates bacterial invasion of 
the host. 
3.2.1 Th1 effector cells 
CD4+ T cells are so-called helper T cells (Th cells) with a specialized function in cytokine 
production in order to activate CTLs as well as B cells and other professional APCs. 
However, CD4+ T cells are also important for the activation of immune cells through 
specific receptor-ligand interactions. Differently polarized subsets of CD4+ T cells including 
Th1, Th2 and Th17 cells secrete distinct patterns of cytokines, which will control the fate of 
the CD4+ mediated immune response in TB. Therefore CD4+ T cells play a central role in 
the induction and maintenance of immune regulation during TB infection. Th1 effector cells 
mainly produce IL-12, IFN-, TNF- and IL-2 and induce cell-mediated immunity which is 
fundamental for immune protection in TB infection. Accordingly, patients with mutations in 
the IL-12 or IFN- receptor genes have a strongly enhanced susceptibility to develop active 
TB (Newport, Huxley et al. 1996; de Jong, Altare et al. 1998). Particularly, IFN- activation 
renders the macrophages capable of killing intracellular mycobacteria by overcoming the 
block in phagosomal maturation and also stimulates production of microbicidal effectors 
including NO. In addition, patients with latent TB who are treated with anti-TNF-
antibodies rapidly develop active TB (Keane, Gershon et al. 2001; Bruns, Meinken et al. 
2009). A newly discovered subset called Th17 cells produce IL-17, IL-22 and IL-23, which has 
been shown to regulate the production of antimicrobial peptides (Liang, Tan et al. 2006) as 
well as the activation and recruitment of IFN- expressing T cells at mucosal sites including 
the lung (Khader, Bell et al. 2007). Th1 and Th17 effector cells cooperate to induce protective 
immunity in TB.  
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3.2.2 Th2 effector cells 
In contrast, Th2 effector cells producing IL-4, IL-5, IL-9 and IL-13, regulate the 
differentiation of antibody secreting plasma cells that has been shown to enhance 
intracellular persistence of M. tuberculosis (Potian, Rafi et al.). Thus, a dominant Th2 
response can undermine Th1-mediated immunity and drive inappropriate alternative 
activation of macrophages (Rook 2007). The traditional view is that IFN- activated or 
classically activated (M1) M. tuberculosis-infected macrophages, produce high amounts of 
proinflammatory cytokines and NO and become highly bactericidal. However, recent 
evidence suggests that the initial M1 activation is followed by alternative activation (M2) of 
M. tuberculosis-infected macrophages in the lung, which would support a switch in 
macrophage polarization upon progression of TB disease (Redente, Higgins et al. 2011). IL-4 
and IL-13 could promote alternative macrophage activation characterized by collagen 
deposition and formation of fibrosis in the inflamed tissue, which are typical traits of 
advanced TB disease. IL-4 and IL-13 have also been shown to block autophagy-mediated 
killing of mycobacteria in both murine and human macrophages (Harris, De Haro et al. 
2007). Thus, M. tuberculosis virulence factors may interfere with M1 polarization and instead 
promote polarization of alternatively activated M2 macrophages or deactivated 
macrophages that are immunosuppressive and poorly microbicidal (Benoit, Desnues et al. 
2008). 
3.2.3 Regulatory T cells  
CD4+ T cells may also be induced to acquire regulatory functions and to secrete 
immunosuppressive cytokines like TGF- and IL-10 rather than the classical Th1 or Th2 
cytokines. There is plenty of evidence that M. tuberculosis can induce specific regulatory T 
(Treg) cells that potently restrict protective immune responses during human TB. Increased 
levels of FoxP3+ Treg cells have been discovered in blood (Ribeiro-Rodrigues, Resende Co et 
al. 2006), lung (Guyot-Revol, Innes et al. 2006), lymph nodes (Rahman, Gudetta et al. 2009) 
and pleura (Chen, Zhou et al. 2007) of patients with active progressive TB. Induction of 
FoxP3+ Treg cells is also evident in murine TB (Shafiani, Tucker-Heard et al.). In vitro 
experiments demonstrate that ManLAM induces expansion of human Treg cells through 
mechanisms that depend on and prostaglandin E2 (PGE2) (Garg, Barnes et al. 2008) or PD1 
(Periasamy, Dhiman et al.). These Treg cells produced significant amounts of TGF- and IL-
10 and inhibited IFN- expression by autologous CD4+ and CD8+ T cells. Several studies 
provide evidence that Treg cells could suppress antigen-specific IFN- production by human 
T cells, by which mechanism they would limit immunopathology but also down-regulate 
cellular immunity in TB (Hougardy, Place et al. 2007; Li, Lao et al. 2007; Li and Wu 2008). 
Thus, local CD4+ T cell responses could be inhibited, which may result in a failure to recruit 
CD8+ effector T cells to the granulomatous lesions in TB. Premature induction of an 
immunosuppressive Treg response may blunt important CTL activity and instead enhance 
pathological alterations in TB infected tissue. 
3.2.4 Polyfunctional T cells 
A popular concept that has been intensively studied is the induction of polyfunctional T 
cells that has been demonstrated to correlate with immune protection in several chronic 
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intracellular infections including TB (Darrah, Patel et al. 2007; Forbes, Sander et al. 2008). 
Polyfunctional T cells are characterized by the simultaneous production of effector 
molecules such as several Th1 cytokine co-expressed with inflammatory chemokines and 
markers for CTL degranulation. Even if several studies show that polyfunctional T cells 
have an impact on TB immunity, we still lack specific immune signatures or correlates of 
immune protection that could be used as specific biomarkers in novel vaccine- and drug 
development. Expansion and activation of Treg cells and Th2 (IL-4, IL-13) cells in chronic TB 
infection may prevent important polyfunctional Th1 responses and the development of fully 
functional CTLs. Our research group applies multicolor flowcytometry, multiplex mRNA 
and luminex analysis to characterize polyfunctionality and unravel the complex network 
and functional relationship between cytokine and chemokine profiles in lung vs systemic 
circulation of patients with active TB compared to uninfected controls. We also plan to use a 
systems biology approach to address immunological defects induced by mycobacteria and 
associated with progression of clinical disease.  
3.2.5 Cytolytic T cells 
CD4+ Th1 cells activate CD8+ CTLs which act in concert with natural killer (NK) cells as 
professional killers of M. tuberculosis-infected target cells. Activation mediated by CD4+ T 
cells or provision of other co-stimulatory signals provided by professional APCs are 
necessary to trigger the differentiation and maturation of CTLs. CTL-induced destruction 
of M. tuberculosis-infected cells is characterized by lysis of the cell membrane as well as 
disruption of the cell nucleus and characteristic fragmentation of target cell DNA. CTL-
mediated lysis is primarily executed by one of two different mechanisms, involving either 
perforin- or Fas/Fas-ligand(L)-based killing. However, whereas perforin-mediated killing 
seems to be crucial for the elimination of infected target cells (Canaday, Wilkinson et al. 
2001), Fas-mediated killing seems to play a major role in lymphocyte homeostasis 
(Kremer, Estaquier et al. 2000; Watson, Hill et al. 2000). Interestingly, M. tuberculosis can 
induce an increased expression of FasL on infected macrophages which may induce 
apoptosis among Fas expressing cells like CTLs and Thl cells (Mustafa, Phyu et al. 1999). 
Death receptor ligand-mediated apoptosis could also lyse M. tuberculosis-infected cells in 
the absence of bacterial killing and thus contribute to activation-induced cell death of 
CTLs. Here, it has been suggested that disease progression is associated with Fas/FasL 
mediated apoptosis of M. tuberculosis-reactive T cells (Li, Bassiri et al. 1998; Rios-Barrera, 
Campos-Pena et al. 2006).  
Hence, only CTLs using the perforin-dependent, granule-mediated pathway of target cell 
killing are effective in decreasing the viability of intracellular M. tuberculosis and properly 
control the infection (Stenger, Mazzaccaro et al. 1997; Lewinsohn, Bement et al. 1998; Silva 
and Lowrie 2000; Samten, Wizel et al. 2003). Perforin is a pore-forming protein that is stored 
in the cytolytic cell within cytoplasmic granules together with other lytic and antimicrobial 
molecules called granzymes and granulysin (Stenger, Hanson et al. 1998; Okada, Li et al. 
2003). Similar to the actions of human cathelicidin, the antimicrobial peptide granulysin can 
interact with the negative cell surface of the bacteria and induce osmotic lysis (Ernst, 
Thoma-Uszynski et al. 2000). Importantly, mice lack a known homologue of granulysin, 
which again indicates that mouse TB is regulated differently from human TB. The capacity 
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of granulysin to kill M. tuberculosis bacilli located inside infected cells is dependent on the 
pore-forming properties of perforin. Upon binding to a specific target cell, the CTL reorients 
these lytic granules to the site of cell-cell contact and releases its contents in the intercellular 
space between itself and the infected target cell. Perforin will integrate into the target cell 
membrane in a Ca2+-dependent manner and create polyperforin pores, which result in 
permeabilization and osmotic failure of the target cell. It is also believed that perforin forms 
pores in cellular membranes to facilitate entry and endosome-mediated transportation of 
granzymes and/or granulysin to the intracellular compartments via a newly identified 
membrane-repair mechanism (Keefe, Shi et al. 2005). Interestingly, we have found that short 
peptides of granulysin are particularly effective in killing of slow-growing multidrug 
resistant TB (MDR-TB) strains with a reduced fitness phenotype (Toro, Hoffner et al. 2006). 
These results suggest that a cost of resistance, measured as reduced growth among MDR-TB 
strains, could be associated with increased susceptibility to natural immune defence 
mechanisms, such as antimicrobial peptides of granulysin. However, a robust cell wall as 
well as the membrane of host cells still provides physical shelter for the bacteria that may 
spare them from being killed. 
Individuals with active, progressive TB disease most likely have an inadequate up-
regulation of M. tuberculosis-specific CD8+ CTLs and cytolytic effector molecules, resulting 
in insufficient killing of infected cells and bacilli at local sites of TB-infection. Importantly, 
impaired CTL function has been associated with the progression of clinical TB disease, 
particularly in anti-TNF treated patients with autoimmune diseases, who demonstrate 
selective depletion of perforin and granulysin expressing CD8+ CTLs (Bruns, Meinken et al. 
2009). We have previously discovered that an impaired expression of both perforin and 
granulysin at the site of TB infection in pulmonary (Andersson, Samarina et al. 2007) and 
lymph node (Rahman, Gudetta et al. 2009) lesions from TB patients correlated with the 
progression of active TB disease. The cause and mechanism behind this impaired expression 
of antimicrobial effector molecules is unknown, but an important subject for future studies 
on human TB. 
3.2.6 Mycobacterial manipulation of T cell effector functions 
Bacterial factors are critical determinants in the decision between Th1 or Th2 polarization, 
and although M. tuberculosis does induce a strong inflammatory host response, Th1 
responses may be delayed and insufficient to eradicate the infection. Mycobacteria may 
skew immune activation toward an improper regulatory or Th2 profile and simultaneously 
inhibit a Th1/Th17 response and a subsequent CTL response. Recent results demonstrate 
that the ESAT-6 protein from M. tuberculosis directly inhibits human T cell proliferation and 
IFN- production in a p38 MAPK-dependent manner (Peng, Wang et al. 2011). It has also 
been shown that apart from IFN-, ESAT-6 can inhibit IL-17 and TNF- production as well 
as expression of early activation markers on human T cells (Wang, Barnes et al. 2009). 
Similarly, the Th1 cell surface molecule Tim3 can stimulate antimicrobial immunity in M. 
tuberculosis-infected macrophages but simultaneously inhibit the expansion of Th1 cells to 
prevent excess tissue inflammation (Jayaraman, Sada-Ovalle et al. 2011). It has also been 
shown that PD1 and its ligands, can inhibit CTL function in human TB (Jurado, Alvarez et 
al. 2008), suggesting that PD1 interferes with T cell effector functions against M. tuberculosis. 
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Thus, the pathogen may have evolved mechanisms to modulate the expression of negative 
regulators including Tim-3 and PD1 to favour bacterial persistence. On the other hand, PD1-
deficient mice are highly susceptible to progressive TB infection and show abnormal 
immune activation including a dramatic increase in proinflammatory cytokines but low 
numbers of lymphocytes infiltrating the lung (Lazar-Molnar, Chen et al. 2011). Importantly, 
a shift of the immune response towards excessive inflammation characterized by extensive 
production of proinflammatiory cytokines such as IL-1, TNF-, IL-6 and IL-17 may promote 
pathology and result in severe tissue damage instead of immune control (Lazar-Molnar, 
Chen et al. 2011; Torrado and Cooper 2011). Hence, a balance between Th1 and Th17 
responses needs to be achieved to control bacterial growth and limit immunopathology in 
the chronic phase of TB infection.  
3.3 Passing checkpoint three  loss of immune control and progression to TB 
Intracellular replication of M. tuberculosis is followed by the release of inflammatory 
mediators and the recruitment of additional immune cells including monocytes, 
macrophages, neutrophils and lymphocyte to the site of infection. The resulting clusters of 
immune cells are known as granuloma, which are immunopathological hallmarks of 
tuberculosis. The formation and organization of the granulomatous inflammatory 
response is believed to contain the infection and to generate an immunological balance 
between the pathogen and the host. Thus, the function of the granuloma is generally 
described to be host-protective in its nature; however, recent research has also provided 
evidence that M. tuberculosis bacteria may use the granuloma as a vehicle to seed the 
infection in the local environment of the lung. It is noteworthy that the major route of 
spread of the infection to other individuals is through the rupture of fully matured 
caseating granuloma, which results in drainage of viable bacteria into the airways. This 
implies that M. tuberculosis would not be a successful pathogen if it would not be able to 
cause necrotic granulomas.  
3.3.1 The granuloma good or bad for the M. tuberculosis-infected host? 
Formation of M.tuberculosis granulomas typically requires the initiation of a delayed-type 
hypersensitivity reaction and chronic inflammation. Granulomas are composed of clusters 
of infected macrophages surrounded by sheets of lymphocytes and fibroblasts that are 
recruited to the site of infection with the aim to contain the infection (Flynn, Chan et al. 
2011). The specific host and bacterial factors that orchester granuloma development are still 
poorly defined. Whereas it is well established that the granuloma is formed as part of the 
protective immune response to M. tuberculosis, there is evidence that mycobacteria can also 
utilize early granuloma formation to seed the infection to uninfected macrophages that are 
recruited to the site of granuloma (Davis and Ramakrishnan 2009). This ability of pathogenic 
mycobacteria to exploit granuloma function is dependent on the ESX-1 secretion system that 
promotes cell death of infected macrophages, which further enhances uptake and expansion 
of bacteria in the local environment. Granulomas are highly dynamic structures with 
multiple appearances in infected organs during active TB disease, including solid non-
necrotizing and caseous necrotic granulomas (Kaplan, Post et al. 2003; Rahman, Gudetta et 
al. 2009). Rupture of mature granulomas drains the caseous necrotic fluid, which is full of 
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viable bacteria, into the airways of patients with TB, followed by expectoration in the form 
of infectious aerosols. This is the only known mechanism for M. tuberculosis to spread to 
other individuals. Therefore, although facing the risk of being restricted or killed by host 
immunity, M. tuberculosis is dependent on mature granulomas and host immunity. 
Interestingly, a recent analysis showed that many T cell antigens are actually conserved in 
virulent M. tuberculosis strains, implying that the bacterium actually wants to be presented 
to the host immune system (Comas, Chakravartti et al. 2011). Taken together, at least in the 
initial and late stages of M. tuberculosis infection, the bacterium takes advantage of the host 
immune response, and host immunity is therefore both protective and detrimental for the 
host during mycobacterial infection, which adds a level of complexity to the understanding 
of TB. 
3.3.2 Manipulation of T cell functions in the granuloma 
Our research group has built a technological platform based on quantitative cell- and tissue 
analysis of clinical materials from TB patients and controls. We have obtained patient 
samples from the site of TB infection and used immunohistology and in situ computerized 
image analysis to assess expression and distribution of CD4+ T cells, CD8+ CTLs and 
antimicrobial effector molecules in M. tuberculosis-infected tissue. Importantly, immune cells 
are recruited and collected at sites where the bacilli reside, i.e. in infected macrophages in 
the lung, lymph nodes, pleura or other organs (Barnes, Mistry et al. 1989; Schwander, Torres 
et al. 1998; Wilkinson, Wilkinson et al. 2005; Jafari, Ernst et al. 2008; Nemeth, Winkler et al. 
2009). Hence, organ-specific cell-cell interactions and the functional expression of different 
proteins can be studied in a physiological environment. Protein expression can be quantified 
at the single-cell level (Bjork, Andersson et al. 1994) using microscopy and a highly sensitive 
digital image analysis system with the ability to detect and separate many million different 
colours. In our studies, we have found that the abundance of CD8+ CTLs expressing the 
important anti-TB effectors perforin and granulysin, are very low in the granulomatous 
lesions (Andersson, Samarina et al. 2007; Rahman, Gudetta et al. 2009), indicating bacterial 
manipulation of host immune functions (Fig. 3). Quantitative real-time mRNA analysis of 
tissue from M.tuberculosis infected lymph nodes revealed that IFN-, TNF- and IL-17 were 
not up-regulated while there was a significant induction of TGF- and IL-13. Whereas CD8+ 
CTLs were absent from the TB lesions, NO-producing macrophages were abundant and the 
expression of the M. tuberculosis-specific antigen MPT64 was high (Fig. 3). These results 
suggest that CTL activation is impaired and that the few effector CTLs that are present in 
the tissue cannot make contact with and kill M. tuberculosis-infected cells, which accumulate 
in the granuloma. Instead, these lesions may provide a protective niche for the bacteria, 
especially at later stages of M. tuberculosis infection after induction of adaptive immunity. 
Whereas compartmentalization of immune responses involved few CD8+ CTLs, we found 
that the levels of FoxP3+ Treg cells and also TGF- were significantly elevated in the 
tuberculous granulomas, suggesting that active immunosuppression takes place at this site 
(Rahman, Gudetta et al. 2009). This methodology provides important information about the 
regulation of immune responses in the microenvironment of the human TB granuloma and 
generates a valuable contribution and complement to the knowledge gained from animal 
and in vitro experimental systems. 
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Fig. 3. Schematic illustration of the expression and distribution of M.tuberculosis infected 
macrophages, T cell subsets and cytolytic and antimicrobial effector molecules inside and 
outside the human granuloma. While macrophages expressing high amounts of the 
M.tuberculosis-specific antigen MPT64 as well as NO synthase are accumulated at the site of 
infection in the granuloma, the ratio of CD8+ CTLs and Treg cells are significantly higher 
outside the lesions. Expression of the important anti-TB effectors perforin and granulysin, is 
low in the infected tissue, and almost absent in the M.tuberculosis granuloma. Impaired CTL 
activation correlates with a low induction of Th1 cytokines, IFN-, TNF- and IL-17, but an 
increased expression of the immunosuppressive cytokines TGF-and IL-13. This type of 
immune response will provide a protective niche for the bacteria inside the granuloma and 
favour bacterial persistence in the host. 
4. Conclusion 
The complex mechanisms that are at play during the development of chronic and acute TB 
involve host immunity and mycobacterial manipulation of both innate and adaptive 
immunity. The tug-of-war between the bacteria and host immune cells has been illustrated 
in this chapter as a spectrum between early infection and active disease. The described 
checkpoints, which M. tuberculosis has to pass in order to cause acute infection, are 
represented by immune mechanisms of increasing complexity, ranging from early innate 
defence to the multifaceted antibacterial effects posed by adaptive immunity. If 
immunological control fails, the pathogen takes advantage of immune activities such as 
excessive release of inflammatory mediators, thus creating the necrotic tissue through which 
it conveys its spread to other individuals. Innovative thinking and new models that can be 
used to address questions on the interaction between host immunity and M. tuberculosis are 
required to move the research field forward towards new knowledge. Thus, by questioning 
old dogmas, many research groups are now approaching the pathogenicity mechanisms of 
M. tuberculosis from new angles, and this is already paying off as improved understanding 
of the disease it causes, which is a promising step towards new therapies. 
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